regulatory
confidence high
sentiment negative
materiality 0.55
Context Therapeutics receives Nasdaq minimum bid price deficiency notice
Context Therapeutics Inc.
- Received Nasdaq deficiency notice on Feb 27, 2025 for failing $1.00 minimum bid price for 30 consecutive business days.
- Initial 180-day cure period runs until August 26, 2025 to regain compliance.
- Must have closing bid price of $1.00+ for at least 10 consecutive business days to cure.
- Company will monitor and evaluate options, but no assurance of regaining compliance.
- If not cured by Aug 26, may be eligible for an additional 180-day grace period.